XERS
Xeris Biopharma Holdings, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website xerispharma.com
- Employees(FY) 355
- ISIN US98422E1038
Performance
+5.32%
1W
+10.0%
1M
-38.51%
3M
+26.11%
6M
-15.74%
YTD
-29.29%
1Y
Profile
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Technical Analysis of XERS 2024-05-10
Overview:
In analyzing the technical indicators for XERS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-10 03:21
- 2024-05-10 00:36
- 2024-05-10 00:27
Q1 2024 Xeris Biopharma Holdings Inc Earnings Call(Yahoo Finance)
- 2024-05-08 23:55
- 2024-05-08 20:10
- 2024-05-08 20:10
- 2024-05-08 19:11
Xeris Biopharma: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-08 19:00
- 2024-05-05 19:42
- 2024-05-05 19:00
- 2024-05-01 19:00
- 2024-04-03 04:05
- 2024-04-01 19:00
- 2024-03-07 00:47
- 2024-03-06 22:56
- 2024-03-06 10:16
Q4 2023 Xeris Biopharma Holdings Inc Earnings Call(Yahoo Finance)
- 2024-03-05 23:52
- 2024-03-05 19:15
- 2024-03-05 18:17
Xeris Biopharma: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-05 18:02
- 2024-03-05 18:00
- 2024-03-04 20:42
- 2024-02-27 18:00
- 2024-02-04 18:00
- 2024-01-10 19:30
- 2024-01-09 19:00
- 2024-01-08 01:48
- 2024-01-05 03:05
- 2024-01-03 18:00
Xeris Biopharma Updates Its Outlook for 2023(Businesswire)
- 2023-12-26 18:00
Page 1 of 5
previousnext